Table 1.
Clinical Information of osteosarcoma patients and healthy controls
| Healthy controls | Nonmetastatic OS patients | Lung metastatic OS patients | |
|---|---|---|---|
| No. of subjects | 30 | 32 | 33 |
| Age, years, mean ± SD | 22 ± 1.55 | 15.28 ± 6.67 | 19.07 ± 10.99 |
| Gender (male/female) | 16/14 | 16/16 | 21/12 |
| Lesion location | |||
| Humerus | 3 | 2 | |
| Femur | 17 | 16 | |
| Tibia | 10 | 12 | |
| Fibula | 2 | 1 | |
| Rib | 0 | 1 | |
| Ilium | 0 | 1 | |
| ALP (U/L) | 222.5 ± 220.3 | 349.7 ± 494.3 | |
| LDH (U/L) | 260.1 ± 109.1 | 328.7 ± 225.0 | |
| Enneking staging | |||
| I | 0 | 0 | |
| II | IIA: 18; IIB: 14 | 0 | |
| III | 0 | 33 | |
OS osteosarcoma, ALP alkaline phosphatase, LDH lactic dehydrogenase